Rare diseases and orphan products :: accelerating research and development /
"Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product developme...
Gespeichert in:
Körperschaft: | |
---|---|
Weitere Verfasser: | , |
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, D.C. :
National Academies Press,
©2010.
|
Schriftenreihe: | Online access: NCBI NCBI Bookshelf.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | "Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development."--Publisher's description |
Beschreibung: | 1 online resource (xxi, 420 pages) : illustrations |
Bibliographie: | Includes bibliographical references (pages 249-282) and index. |
ISBN: | 9780309158077 0309158079 1283044560 9781283044561 9786613044563 6613044563 0309209919 9780309209915 |
Internformat
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocn711000622 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 110404s2010 dcua ob 001 0 eng d | ||
010 | |z 2010052788 | ||
040 | |a N$T |b eng |e pn |c N$T |d E7B |d COF |d NATAP |d YDXCP |d OCLCQ |d NLGGC |d MMU |d CDX |d AZM |d ZMC |d IDEBK |d OCLCQ |d EBLCP |d OCLCQ |d AZK |d YDX |d VT2 |d OCLCQ |d OCLCO |d TOA |d OCLCO |d AGLDB |d MOR |d PIFAG |d ZCU |d OCLCO |d OTZ |d OCLCQ |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d BUF |d OCLCO |d OCLCF |d STF |d VNS |d WRM |d OCLCQ |d VTS |d COCUF |d NRAMU |d ICG |d MERER |d CUY |d AU@ |d OCLCO |d WYU |d OCLCO |d OCLCQ |d LVT |d YOU |d OCLCQ |d DKC |d OCLCQ |d M8D |d UX1 |d UKAHL |d OCLCQ |d VLY |d TKN |d OCLCQ |d SDF |d TUHNV |d OCLCO |d DST |d OCLCO |d SFB |d OCLCQ |d OCL |d OCLCO |d OCLCL |d OCLCA |d OCLCL | ||
016 | 7 | |a 101549696 |2 DNLM | |
019 | |a 706475292 |a 781287083 |a 816829642 |a 923282998 |a 961506948 |a 962574070 |a 971070577 |a 988521188 |a 991962412 |a 994983249 |a 1021249553 |a 1028771576 |a 1037901208 |a 1038653111 |a 1045476405 |a 1048174540 |a 1055338944 |a 1062898028 |a 1064769364 |a 1162542848 |a 1200879077 |a 1229430789 |a 1241767785 |a 1249225801 |a 1290061308 |a 1300525838 | ||
020 | |a 9780309158077 |q (electronic bk.) | ||
020 | |a 0309158079 |q (electronic bk.) | ||
020 | |a 1283044560 | ||
020 | |a 9781283044561 | ||
020 | |a 9786613044563 | ||
020 | |a 6613044563 | ||
020 | |z 9780309158060 | ||
020 | |z 0309158060 | ||
020 | |a 0309209919 | ||
020 | |a 9780309209915 | ||
035 | |a (OCoLC)711000622 |z (OCoLC)706475292 |z (OCoLC)781287083 |z (OCoLC)816829642 |z (OCoLC)923282998 |z (OCoLC)961506948 |z (OCoLC)962574070 |z (OCoLC)971070577 |z (OCoLC)988521188 |z (OCoLC)991962412 |z (OCoLC)994983249 |z (OCoLC)1021249553 |z (OCoLC)1028771576 |z (OCoLC)1037901208 |z (OCoLC)1038653111 |z (OCoLC)1045476405 |z (OCoLC)1048174540 |z (OCoLC)1055338944 |z (OCoLC)1062898028 |z (OCoLC)1064769364 |z (OCoLC)1162542848 |z (OCoLC)1200879077 |z (OCoLC)1229430789 |z (OCoLC)1241767785 |z (OCoLC)1249225801 |z (OCoLC)1290061308 |z (OCoLC)1300525838 | ||
050 | 4 | |a RS420 |b .R357 2010eb | |
060 | 4 | |a QV 736 |b R221 2010 | |
072 | 7 | |a MED |x 023000 |2 bisacsh | |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
072 | 7 | |a MED |x 072000 |2 bisacsh | |
072 | 7 | |a MED |x 058170 |2 bisacsh | |
082 | 7 | |a 615/.19 |2 22 | |
049 | |a MAIN | ||
245 | 0 | 0 | |a Rare diseases and orphan products : |b accelerating research and development / |c Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies. |
260 | |a Washington, D.C. : |b National Academies Press, |c ©2010. | ||
300 | |a 1 online resource (xxi, 420 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
504 | |a Includes bibliographical references (pages 249-282) and index. | ||
505 | 0 | |a Profile of rare diseases -- Regulatory framework for drugs for rare diseases -- Discovery research for rare diseases and orphan product development -- Development of new therapeutic drugs and biologics for rare diseases -- Coverage and reimbursement : incentives and disincentives for product development -- Medical devices : research and development for rare diseases -- Toward an integrated approach to accelerating research and product development for rare diseases. | |
588 | 0 | |a Print version record. | |
520 | |a "Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development."--Publisher's description | ||
546 | |a English. | ||
650 | 0 | |a Orphan drugs. |0 http://id.loc.gov/authorities/subjects/sh85095747 | |
650 | 0 | |a Drugs |x Design. |0 http://id.loc.gov/authorities/subjects/sh88001157 | |
650 | 0 | |a Rare diseases |x Treatment. | |
650 | 0 | |a Medical policy. |0 http://id.loc.gov/authorities/subjects/sh85083002 | |
650 | 1 | 2 | |a Orphan Drug Production |0 https://id.nlm.nih.gov/mesh/D009965 |
650 | 1 | 2 | |a Rare Diseases |x drug therapy |0 https://id.nlm.nih.gov/mesh/D035583Q000188 |
650 | 2 | 2 | |a Drug Discovery |0 https://id.nlm.nih.gov/mesh/D055808 |
650 | 2 | 2 | |a Drug Evaluation |0 https://id.nlm.nih.gov/mesh/D004341 |
650 | 2 | 2 | |a Health Policy |0 https://id.nlm.nih.gov/mesh/D006291 |
650 | 2 | 2 | |a Policy Making |0 https://id.nlm.nih.gov/mesh/D011050 |
650 | 2 | |a Drug Design |0 https://id.nlm.nih.gov/mesh/D015195 | |
650 | 6 | |a Médicaments orphelins. | |
650 | 6 | |a Médicaments |x Conception. | |
650 | 6 | |a Maladies rares |x Traitement. | |
650 | 6 | |a Politique sanitaire. | |
650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
650 | 7 | |a Medical policy |2 fast | |
650 | 7 | |a Drugs |x Design |2 fast | |
650 | 7 | |a Orphan drugs |2 fast | |
655 | 2 | |a Evaluation Study. | |
700 | 1 | |a Field, Marilyn J. |q (Marilyn Jane) |1 https://id.oclc.org/worldcat/entity/E39PCjxm3pQ6GBFrkx6rkvwP73 |0 http://id.loc.gov/authorities/names/n83205699 | |
700 | 1 | |a Boat, Thomas F. |0 http://id.loc.gov/authorities/names/n96802649 | |
710 | 2 | |a Institute of Medicine (U.S.). |b Committee on Accelerating Rare Diseases Research and Orphan Product Development. |0 http://id.loc.gov/authorities/names/n2010185178 | |
758 | |i has work: |a Rare diseases and orphan products (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFFpJXQTJFtxDCHGv7V6cd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |t Rare diseases and orphan products. |d Washington, D.C. : National Academies Press, ©2010 |z 9780309158060 |w (DLC) 2010052788 |w (OCoLC)681488330 |
830 | 0 | |a Online access: NCBI NCBI Bookshelf. | |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=361655 |3 Volltext |
938 | |a Askews and Holts Library Services |b ASKH |n AH36617342 | ||
938 | |a Askews and Holts Library Services |b ASKH |n AH36559431 | ||
938 | |a Coutts Information Services |b COUT |n 17639522 | ||
938 | |a ProQuest Ebook Central |b EBLB |n EBL3378753 | ||
938 | |a ebrary |b EBRY |n ebr10459089 | ||
938 | |a EBSCOhost |b EBSC |n 361655 | ||
938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 304456 | ||
938 | |a YBP Library Services |b YANK |n 3875157 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocn711000622 |
---|---|
_version_ | 1816881755247869952 |
adam_text | |
any_adam_object | |
author2 | Field, Marilyn J. (Marilyn Jane) Boat, Thomas F. |
author2_role | |
author2_variant | m j f mj mjf t f b tf tfb |
author_GND | http://id.loc.gov/authorities/names/n83205699 http://id.loc.gov/authorities/names/n96802649 |
author_corporate | Institute of Medicine (U.S.). Committee on Accelerating Rare Diseases Research and Orphan Product Development |
author_corporate_role | |
author_facet | Field, Marilyn J. (Marilyn Jane) Boat, Thomas F. Institute of Medicine (U.S.). Committee on Accelerating Rare Diseases Research and Orphan Product Development |
author_sort | Field, Marilyn J. |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RS420 |
callnumber-raw | RS420 .R357 2010eb |
callnumber-search | RS420 .R357 2010eb |
callnumber-sort | RS 3420 R357 42010EB |
callnumber-subject | RS - Pharmacy |
collection | ZDB-4-EBA |
contents | Profile of rare diseases -- Regulatory framework for drugs for rare diseases -- Discovery research for rare diseases and orphan product development -- Development of new therapeutic drugs and biologics for rare diseases -- Coverage and reimbursement : incentives and disincentives for product development -- Medical devices : research and development for rare diseases -- Toward an integrated approach to accelerating research and product development for rare diseases. |
ctrlnum | (OCoLC)711000622 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06431cam a2200973 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn711000622</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">110404s2010 dcua ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2010052788</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">E7B</subfield><subfield code="d">COF</subfield><subfield code="d">NATAP</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">MMU</subfield><subfield code="d">CDX</subfield><subfield code="d">AZM</subfield><subfield code="d">ZMC</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">YDX</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OTZ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">ICG</subfield><subfield code="d">MERER</subfield><subfield code="d">CUY</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">LVT</subfield><subfield code="d">YOU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">UX1</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VLY</subfield><subfield code="d">TKN</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SDF</subfield><subfield code="d">TUHNV</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DST</subfield><subfield code="d">OCLCO</subfield><subfield code="d">SFB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101549696</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">706475292</subfield><subfield code="a">781287083</subfield><subfield code="a">816829642</subfield><subfield code="a">923282998</subfield><subfield code="a">961506948</subfield><subfield code="a">962574070</subfield><subfield code="a">971070577</subfield><subfield code="a">988521188</subfield><subfield code="a">991962412</subfield><subfield code="a">994983249</subfield><subfield code="a">1021249553</subfield><subfield code="a">1028771576</subfield><subfield code="a">1037901208</subfield><subfield code="a">1038653111</subfield><subfield code="a">1045476405</subfield><subfield code="a">1048174540</subfield><subfield code="a">1055338944</subfield><subfield code="a">1062898028</subfield><subfield code="a">1064769364</subfield><subfield code="a">1162542848</subfield><subfield code="a">1200879077</subfield><subfield code="a">1229430789</subfield><subfield code="a">1241767785</subfield><subfield code="a">1249225801</subfield><subfield code="a">1290061308</subfield><subfield code="a">1300525838</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309158077</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309158079</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283044560</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283044561</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786613044563</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6613044563</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309158060</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309158060</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309209919</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309209915</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)711000622</subfield><subfield code="z">(OCoLC)706475292</subfield><subfield code="z">(OCoLC)781287083</subfield><subfield code="z">(OCoLC)816829642</subfield><subfield code="z">(OCoLC)923282998</subfield><subfield code="z">(OCoLC)961506948</subfield><subfield code="z">(OCoLC)962574070</subfield><subfield code="z">(OCoLC)971070577</subfield><subfield code="z">(OCoLC)988521188</subfield><subfield code="z">(OCoLC)991962412</subfield><subfield code="z">(OCoLC)994983249</subfield><subfield code="z">(OCoLC)1021249553</subfield><subfield code="z">(OCoLC)1028771576</subfield><subfield code="z">(OCoLC)1037901208</subfield><subfield code="z">(OCoLC)1038653111</subfield><subfield code="z">(OCoLC)1045476405</subfield><subfield code="z">(OCoLC)1048174540</subfield><subfield code="z">(OCoLC)1055338944</subfield><subfield code="z">(OCoLC)1062898028</subfield><subfield code="z">(OCoLC)1064769364</subfield><subfield code="z">(OCoLC)1162542848</subfield><subfield code="z">(OCoLC)1200879077</subfield><subfield code="z">(OCoLC)1229430789</subfield><subfield code="z">(OCoLC)1241767785</subfield><subfield code="z">(OCoLC)1249225801</subfield><subfield code="z">(OCoLC)1290061308</subfield><subfield code="z">(OCoLC)1300525838</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS420</subfield><subfield code="b">.R357 2010eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 736</subfield><subfield code="b">R221 2010</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">023000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">072000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">058170</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Rare diseases and orphan products :</subfield><subfield code="b">accelerating research and development /</subfield><subfield code="c">Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2010.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xxi, 420 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 249-282) and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Profile of rare diseases -- Regulatory framework for drugs for rare diseases -- Discovery research for rare diseases and orphan product development -- Development of new therapeutic drugs and biologics for rare diseases -- Coverage and reimbursement : incentives and disincentives for product development -- Medical devices : research and development for rare diseases -- Toward an integrated approach to accelerating research and product development for rare diseases.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development."--Publisher's description</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Orphan drugs.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85095747</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Design.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh88001157</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Rare diseases</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical policy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85083002</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Orphan Drug Production</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D009965</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Rare Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D035583Q000188</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Discovery</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D055808</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Evaluation</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004341</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Health Policy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D006291</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Policy Making</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D011050</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Design</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D015195</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments orphelins.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Conception.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Maladies rares</subfield><subfield code="x">Traitement.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Politique sanitaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Drug Guides.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacy.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Nursing</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="x">Design</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Orphan drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Evaluation Study.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Field, Marilyn J.</subfield><subfield code="q">(Marilyn Jane)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjxm3pQ6GBFrkx6rkvwP73</subfield><subfield code="0">http://id.loc.gov/authorities/names/n83205699</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boat, Thomas F.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n96802649</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Committee on Accelerating Rare Diseases Research and Orphan Product Development.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010185178</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Rare diseases and orphan products (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFFpJXQTJFtxDCHGv7V6cd</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Rare diseases and orphan products.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2010</subfield><subfield code="z">9780309158060</subfield><subfield code="w">(DLC) 2010052788</subfield><subfield code="w">(OCoLC)681488330</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Online access: NCBI NCBI Bookshelf.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=361655</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36617342</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36559431</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">17639522</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3378753</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10459089</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">361655</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">304456</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3875157</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
genre | Evaluation Study. |
genre_facet | Evaluation Study. |
id | ZDB-4-EBA-ocn711000622 |
illustrated | Illustrated |
indexdate | 2024-11-27T13:17:45Z |
institution | BVB |
institution_GND | http://id.loc.gov/authorities/names/n2010185178 |
isbn | 9780309158077 0309158079 1283044560 9781283044561 9786613044563 6613044563 0309209919 9780309209915 |
language | English |
oclc_num | 711000622 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource (xxi, 420 pages) : illustrations |
psigel | ZDB-4-EBA |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | National Academies Press, |
record_format | marc |
series | Online access: NCBI NCBI Bookshelf. |
spelling | Rare diseases and orphan products : accelerating research and development / Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, ©2010. 1 online resource (xxi, 420 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references (pages 249-282) and index. Profile of rare diseases -- Regulatory framework for drugs for rare diseases -- Discovery research for rare diseases and orphan product development -- Development of new therapeutic drugs and biologics for rare diseases -- Coverage and reimbursement : incentives and disincentives for product development -- Medical devices : research and development for rare diseases -- Toward an integrated approach to accelerating research and product development for rare diseases. Print version record. "Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development."--Publisher's description English. Orphan drugs. http://id.loc.gov/authorities/subjects/sh85095747 Drugs Design. http://id.loc.gov/authorities/subjects/sh88001157 Rare diseases Treatment. Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Orphan Drug Production https://id.nlm.nih.gov/mesh/D009965 Rare Diseases drug therapy https://id.nlm.nih.gov/mesh/D035583Q000188 Drug Discovery https://id.nlm.nih.gov/mesh/D055808 Drug Evaluation https://id.nlm.nih.gov/mesh/D004341 Health Policy https://id.nlm.nih.gov/mesh/D006291 Policy Making https://id.nlm.nih.gov/mesh/D011050 Drug Design https://id.nlm.nih.gov/mesh/D015195 Médicaments orphelins. Médicaments Conception. Maladies rares Traitement. Politique sanitaire. MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Medical policy fast Drugs Design fast Orphan drugs fast Evaluation Study. Field, Marilyn J. (Marilyn Jane) https://id.oclc.org/worldcat/entity/E39PCjxm3pQ6GBFrkx6rkvwP73 http://id.loc.gov/authorities/names/n83205699 Boat, Thomas F. http://id.loc.gov/authorities/names/n96802649 Institute of Medicine (U.S.). Committee on Accelerating Rare Diseases Research and Orphan Product Development. http://id.loc.gov/authorities/names/n2010185178 has work: Rare diseases and orphan products (Text) https://id.oclc.org/worldcat/entity/E39PCFFpJXQTJFtxDCHGv7V6cd https://id.oclc.org/worldcat/ontology/hasWork Print version: Rare diseases and orphan products. Washington, D.C. : National Academies Press, ©2010 9780309158060 (DLC) 2010052788 (OCoLC)681488330 Online access: NCBI NCBI Bookshelf. FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=361655 Volltext |
spellingShingle | Rare diseases and orphan products : accelerating research and development / Online access: NCBI NCBI Bookshelf. Profile of rare diseases -- Regulatory framework for drugs for rare diseases -- Discovery research for rare diseases and orphan product development -- Development of new therapeutic drugs and biologics for rare diseases -- Coverage and reimbursement : incentives and disincentives for product development -- Medical devices : research and development for rare diseases -- Toward an integrated approach to accelerating research and product development for rare diseases. Orphan drugs. http://id.loc.gov/authorities/subjects/sh85095747 Drugs Design. http://id.loc.gov/authorities/subjects/sh88001157 Rare diseases Treatment. Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Orphan Drug Production https://id.nlm.nih.gov/mesh/D009965 Rare Diseases drug therapy https://id.nlm.nih.gov/mesh/D035583Q000188 Drug Discovery https://id.nlm.nih.gov/mesh/D055808 Drug Evaluation https://id.nlm.nih.gov/mesh/D004341 Health Policy https://id.nlm.nih.gov/mesh/D006291 Policy Making https://id.nlm.nih.gov/mesh/D011050 Drug Design https://id.nlm.nih.gov/mesh/D015195 Médicaments orphelins. Médicaments Conception. Maladies rares Traitement. Politique sanitaire. MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Medical policy fast Drugs Design fast Orphan drugs fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85095747 http://id.loc.gov/authorities/subjects/sh88001157 http://id.loc.gov/authorities/subjects/sh85083002 https://id.nlm.nih.gov/mesh/D009965 https://id.nlm.nih.gov/mesh/D035583Q000188 https://id.nlm.nih.gov/mesh/D055808 https://id.nlm.nih.gov/mesh/D004341 https://id.nlm.nih.gov/mesh/D006291 https://id.nlm.nih.gov/mesh/D011050 https://id.nlm.nih.gov/mesh/D015195 |
title | Rare diseases and orphan products : accelerating research and development / |
title_auth | Rare diseases and orphan products : accelerating research and development / |
title_exact_search | Rare diseases and orphan products : accelerating research and development / |
title_full | Rare diseases and orphan products : accelerating research and development / Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies. |
title_fullStr | Rare diseases and orphan products : accelerating research and development / Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies. |
title_full_unstemmed | Rare diseases and orphan products : accelerating research and development / Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies. |
title_short | Rare diseases and orphan products : |
title_sort | rare diseases and orphan products accelerating research and development |
title_sub | accelerating research and development / |
topic | Orphan drugs. http://id.loc.gov/authorities/subjects/sh85095747 Drugs Design. http://id.loc.gov/authorities/subjects/sh88001157 Rare diseases Treatment. Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Orphan Drug Production https://id.nlm.nih.gov/mesh/D009965 Rare Diseases drug therapy https://id.nlm.nih.gov/mesh/D035583Q000188 Drug Discovery https://id.nlm.nih.gov/mesh/D055808 Drug Evaluation https://id.nlm.nih.gov/mesh/D004341 Health Policy https://id.nlm.nih.gov/mesh/D006291 Policy Making https://id.nlm.nih.gov/mesh/D011050 Drug Design https://id.nlm.nih.gov/mesh/D015195 Médicaments orphelins. Médicaments Conception. Maladies rares Traitement. Politique sanitaire. MEDICAL Drug Guides. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh MEDICAL Nursing Pharmacology. bisacsh Medical policy fast Drugs Design fast Orphan drugs fast |
topic_facet | Orphan drugs. Drugs Design. Rare diseases Treatment. Medical policy. Orphan Drug Production Rare Diseases drug therapy Drug Discovery Drug Evaluation Health Policy Policy Making Drug Design Médicaments orphelins. Médicaments Conception. Maladies rares Traitement. Politique sanitaire. MEDICAL Drug Guides. MEDICAL Pharmacology. MEDICAL Pharmacy. MEDICAL Nursing Pharmacology. Medical policy Drugs Design Orphan drugs Evaluation Study. |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=361655 |
work_keys_str_mv | AT fieldmarilynj rarediseasesandorphanproductsacceleratingresearchanddevelopment AT boatthomasf rarediseasesandorphanproductsacceleratingresearchanddevelopment AT instituteofmedicineuscommitteeonacceleratingrarediseasesresearchandorphanproductdevelopment rarediseasesandorphanproductsacceleratingresearchanddevelopment |